KyFect™ - AAV Transfection Reagent (14570)
KyFect™ - AAV Transfection Reagent (14570)
KyFect™ - AAV Transfection Reagent (14570)
Roll over image to zoom in Click on image to zoom
KyFect™ - AAV Transfection Reagent (14570)KyFect™ - AAV Transfection Reagent (14570)KyFect™ - AAV Transfection Reagent (14570)
Download Product Brochure

KyFect™ - AAV Transfection Reagent (14570)

KyFect™ - AAV is a next-generation, fully synthetic transfection reagent that delivers high AAV titers, seamless scalability, and exceptional lot-to-lot consistency—all while lowering your cost per run.

SKU Size: 14570-1 (1mL)
Contact Us for Pricing

Looking for large quantities? Submit a Bulk Request.

Introducing KyFect™ - AAV: a next-generation transfection reagent engineered for adeno-associated virus (AAV) production. Built for flexibility and scale, it enables efficient plasmid delivery, high-yield viral titers, and reproducible performance from early-stage discovery through upstream process development. Fully synthetic and manufactured entirely in-house in Pennsylvania, KyFect™ - AAV offers reliable supply, reduced lead times, and complete quality control. Whether you're optimizing your workflow or ramping up production, KyFect™ - AAV empowers you to accelerate progress with greater speed and efficiency.

 

Store At Temperature 2 - 8°C
Shipping Condition Cold Pack

High AAV titers, every time

  • Consistently efficient plasmid transfection resulting in 2x viral titers versus market alternates.

Scalability from flask to bioreactor

  • Reliable performance across formats, from small-scale shake flasks to large-scale bioreactors.

Unmatched flexibility

  • Supports a range of AAV serotypes, DNA concentrations and ratios, complexation times, as well as adherent and suspension HEK293-based production platforms. 

Cost-Efficiency Without Compromise

  • Reduce plasmid usage, increase productivity, and lower cost per dose—without sacrificing performance.

Made in the USA

  • Fully synthetic and manufactured in-house in Pennsylvania for reliable supply and quality control.

GMP Grade Coming Soon

  • Seamless transition from process development to commercialization.
  • Upstream process development for cell and gene therapy  
  • Academic and translational research 

Introducing KyFect™ - AAV: a next-generation transfection reagent engineered for adeno-associated virus (AAV) production. Built for flexibility and scale, it enables efficient plasmid delivery, high-yield viral titers, and reproducible performance from early-stage discovery through upstream process development. Fully synthetic and manufactured entirely in-house in Pennsylvania, KyFect™ - AAV offers reliable supply, reduced lead times, and complete quality control. Whether you're optimizing your workflow or ramping up production, KyFect™ - AAV empowers you to accelerate progress with greater speed and efficiency.

 

Store At Temperature 2 - 8°C
Shipping Condition Cold Pack

High AAV titers, every time

  • Consistently efficient plasmid transfection resulting in 2x viral titers versus market alternates.

Scalability from flask to bioreactor

  • Reliable performance across formats, from small-scale shake flasks to large-scale bioreactors.

Unmatched flexibility

  • Supports a range of AAV serotypes, DNA concentrations and ratios, complexation times, as well as adherent and suspension HEK293-based production platforms. 

Cost-Efficiency Without Compromise

  • Reduce plasmid usage, increase productivity, and lower cost per dose—without sacrificing performance.

Made in the USA

  • Fully synthetic and manufactured in-house in Pennsylvania for reliable supply and quality control.

GMP Grade Coming Soon

  • Seamless transition from process development to commercialization.
  • Upstream process development for cell and gene therapy  
  • Academic and translational research 

You may also like

Recently viewed